NEW YORK, May 30, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GoodRx investors who were adversely affected by alleged securities fraud between September 23, 2022 and November 8, 2022. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/goodrx-lawsuit-submission ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of GoodRx Holdings, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's revenue sources and business operations [1][2]. Group 1: Allegations - The complaint alleges that during the class period from September 23, 2022, to November 8, 2022, GoodRx misrepresented its reliance on Kroger, which accounted for nearly 25% of its total prescription transactions revenue despite representing less than 5% of pharmacies accepting GoodRx discounts [1]. - It is claimed that Kroger had the ability to unilaterally stop accepting GoodRx discounts, which could significantly impact GoodRx's revenue from Kroger pharmacies [1]. - The allegations suggest that the defendants' statements regarding GoodRx's business, operations, and future prospects were materially false and misleading, lacking a reasonable basis [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares of GoodRx during the specified class period are encouraged to register for the class action by June 21, 2024, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's progress [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

RADNOR, Pa., May 27, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) ("GoodRx" or the "Company") on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, and November 8, 2022, inclusive (the "Class Period"). his action, captioned Barsuli v. GoodRx Holdings, Inc., et al., Case No. Case 2:24-cv-03282- DDP-AJR was filed in ...

No fewer than five analysts have lifted their price target in the last week GoodRx Holdings Inc (NASDAQ:GDRX) stock is on the rise today, after an upgrade from RBC to "outperform" from "market perform," with a price-target hike to $10 from $8. This is just the latest in a string of bull notes for the stock, as GDRX has received five price-target hikes since a Raymond James upgrade a week ago. At last glance, GoodRx stock was up 2% at $7.35, earlier as high as $7.80. The equity has been trading choppily, wit ...

NEW YORK, May 23, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GoodRx investors who were adversely affected by alleged securities fraud between September 23, 2022 and November 8, 2022. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/goodrx-lawsuit-submission ...

NEW YORK, May 21, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022, both dates inclusive (the "Class Period"), of the important June 21, 2024 lead plaintiff deadline. WHAT TO DO NEXT: To join the GoodRx class action, go to https://rosenlegal.com/submit-form/? case_id=24355 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for info ...

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by tel ...

The class action concerns whether GoodRx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged ...

Group 1: GoodRx Holdings Inc (GDRX) - GoodRx stock is experiencing a significant increase, up 8.8% to $7.91, following an upgrade from Raymond James to "outperform" and a price target increase from $14 to $16 [1] - The stock has risen 18.2% since the beginning of the year, indicating positive momentum [1] - The recent surge is attributed to the company's inaugural investor day and a prescription contracting agreement with Kroger [1] Group 2: Bumble Inc (BMBL) - Bumble stock is up 0.2% to $11.99, showing a notable uptrend since its record low of $9.83 on May 8 [2] - The stock has broken above several short-term moving averages, including the 60-day trendline, indicating a potential recovery [2] - Short interest represents 9.3% of BMBL's available float, suggesting some potential for a short squeeze [2] Group 3: Market Context - Both GoodRx and Bumble stocks exhibit short squeeze potential, with short interest at 10.8% for GDRX and 9.3% for BMBL [2]

RADNOR, Pa., May 15, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) ("GoodRx" or the "Company") on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, and November 8, 2022, inclusive (the "Class Period"). This action, captioned Barsuli v. GoodRx Holdings, Inc., et al., Case No. Case 2:24-cv-03282- DDP-AJR was filed i ...